BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7563101)

  • 1. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine.
    Mullane K; Bullough D
    J Mol Cell Cardiol; 1995 Apr; 27(4):1041-54. PubMed ID: 7563101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acadesine lowers temporal threshold for the myocardial infarct size limiting effect of preconditioning.
    Tsuchida A; Liu GS; Mullane K; Downey JM
    Cardiovasc Res; 1993 Jan; 27(1):116-20. PubMed ID: 8458021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism.
    Zhao ZQ; Williams MW; Sato H; Hudspeth DA; McGee DS; Vinten-Johansen J; Van Wylen DG
    Cardiovasc Res; 1995 Apr; 29(4):495-505. PubMed ID: 7796443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
    Armstrong S; Ganote CE
    Cardiovasc Res; 1994 Jul; 28(7):1049-56. PubMed ID: 7525060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acadesine extends the window of protection afforded by ischaemic preconditioning.
    Tsuchida A; Yang XM; Burckhartt B; Mullane KM; Cohen MV; Downey JM
    Cardiovasc Res; 1994 Mar; 28(3):379-83. PubMed ID: 8174159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acadesine improves tolerance to ischemic injury in rat cardiac myocytes.
    Gruver EJ; Toupin D; Smith TW; Marsh JD
    J Mol Cell Cardiol; 1994 Sep; 26(9):1187-95. PubMed ID: 7815461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits.
    Burckhartt B; Yang XM; Tsuchida A; Mullane KM; Downey JM; Cohen MV
    Cardiovasc Res; 1995 May; 29(5):653-7. PubMed ID: 7606753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acadesine: a unique cardioprotective agent for myocardial ischemia.
    Nawarskas JJ
    Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning".
    Takaoka A; Nakae I; Mitsunami K; Yabe T; Morikawa S; Inubushi T; Kinoshita M
    J Am Coll Cardiol; 1999 Feb; 33(2):556-64. PubMed ID: 9973039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium.
    Engler RL
    J Card Surg; 1994 May; 9(3 Suppl):482-92. PubMed ID: 8069041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart.
    Schreieck J; Richardt G
    J Mol Cell Cardiol; 1999 Jan; 31(1):123-34. PubMed ID: 10072721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
    GaliƱanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amp 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors.
    Xu Z; Downey JM; Cohen MV
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):474-81. PubMed ID: 11486252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-inflammatory potential of adenosine in ischemia-reperfusion injury: established and putative beneficial actions of a retaliatory metabolite.
    Bouma MG; van den Wildenberg FA; Buurman WA
    Shock; 1997 Nov; 8(5):313-20. PubMed ID: 9361340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?
    Yellon DM; Baxter GF
    J Mol Cell Cardiol; 1995 Apr; 27(4):1023-34. PubMed ID: 7563099
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.
    Liu GS; Richards SC; Olsson RA; Mullane K; Walsh RS; Downey JM
    Cardiovasc Res; 1994 Jul; 28(7):1057-61. PubMed ID: 7954592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes.
    Bullough DA; Magill MJ; Firestein GS; Mullane KM
    J Immunol; 1995 Sep; 155(5):2579-86. PubMed ID: 7650388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement by 5-amino-4-imidazole carboxamide riboside of the contractile dysfunction that follows brief periods of ischemia through increases in ecto-5-nucleotidase activity and adenosine release in canine hearts.
    Kitakaze M; Takashima S; Minamino T; Node K; Shinozaki Y; Mori H; Kuzuya T; Hori M
    Jpn Circ J; 1999 Jul; 63(7):542-53. PubMed ID: 10462022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.